Open AccessDufaston (degidrosteron) in treatment of dysfunctional womb bleeding associated with ferrum hyperplasia of endometrium
Author(s) -
Е. А. Ульрих,
Galiya Fettyakhovna Kutusheva,
А. Ф. Урманчеева
Publication year - 2003
Publication title -
žurnalʺ akušerstva i ženskihʺ boleznej
Language(s) - English
Resource type - Journals
eISSN - 1684-0461
pISSN - 1683-9366
DOI - 10.17816/jowd88982
Subject(s) - medicine , dysfunctional uterine bleeding , endometrium , hyperplasia , endometrial hyperplasia , dysfunctional family , somatic cell , gynecology , physiology , endocrinology , clinical psychology , biochemistry , chemistry , gene
Endometrial hyperplasia, being a fairly common gynecological pathology among women of different age groups, requires timely diagnosis and adequate treatment. Duphaston at a dosage of 10-20 mg from 5 to 25 or from 16 to 25 days of the menstrual cycle showed itself as an effective drug (in 83.3%), with sufficient progestogenic antiproliferative activity, with minimal side effects and a neutral effect on the metabolism of lipids and carbohydrates , which made it possible to use it among patients with various somatic pathologies.